PTHS compared with CNTB: revenue, margins and what each company keeps, and the suppliers and customers both name

PTHSPelthos Therapeutics Inc.

Mkt capRevenueRevenue

CNTBConnect Biopharma Holdings Ltd

Mkt capRevenueRevenue

Compare

PTHSPelthos Therapeutics Inc.

CNTBConnect Biopharma Holdings Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PTHS

Reportimpliedrealized× implied

Q2 FY26—▲+0.14%—

May 14 '26—▲+6.46%—

Q1 FY26—▼−4.62%—

Nov 13 '25—▼−7.27%—

CNTB1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.7%▲+9.01%×0.30

= impliedPTHS realized, solidCNTB realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

PTHSPelthos Therapeutics Inc.

11.38▲+22.31%· post 9.48

Mkt cap$35.8MRevenue$16MQ2 FY26

CNTBConnect Biopharma Holdings Ltd

0.73▼−0.82%· post 0.73

ClosedNov 6 '26

Mkt cap$45.8MRevenue$3MQ2 FY26

Compare

ClosedNov 6 '26

PTHSPelthos Therapeutics Inc.

CNTBConnect Biopharma Holdings Ltd

11.38▲+22.31%post 9.48

Price

0.73▼−0.82%post 0.73

$35.8M

Mkt cap

$45.8M

Q2 FY26$16M

Revenue

$3MQ2 FY26

PTHS11.38▲+22.31%vsCNTB0.73▼−0.82%ClosedNov 6 '26